Part D/Prescription Drugs – Page 60 – medicarereport.org

Friday, September 11, 2026

Latest:

Medicare - General Medicare Advantage Medigap Part D/Prescription Drugs

Eileen Cook September 26, 2022September 26, 2022 medicare, Medicare Advantage, Medigap

What Is Medicare Supplemental Insurance

Medicare Supplement Insurance or Medigap helps fill “gaps” in Original Medicare and is sold by private companies. Original Medicare pays

Health Care Finance Health Care Redesign Legislative Update Medicaid Medicare - General Part D/Prescription Drugs

Eileen Cook September 23, 2022September 23, 2022 Inflation Reduction Act of 2022, Medicare Part D

Explaining the Prescription Drug Provisions in the Inflation Reduction Act

(By Juliette Cubanski, Tricia Neuman, and Meredith Freed for Kaiser Family Foundation Published: Sep 22, 2022) The Inflation Reduction Act

FDA Part D/Prescription Drugs

Eileen Cook September 21, 2022September 21, 2022 ALS, FDA

FDA seems poised to approve a new drug for ALS, but does it work?

(By Jon Hamilton for NPR) The Food and Drug Administration is likely to approve a controversial new drug for ALS

Medicare - General Medicare Advantage Medigap Part D/Prescription Drugs

Eileen Cook September 19, 2022September 19, 2022 medicare, Medicare Advantage, Medigap

A Review of 62 Studies Finds Few Big Differences Between Traditional Medicare and Medicare Advantage on a Variety of Measures

(By Chris Lee for Kaiser Family Foundation published September 16, 2022) With the Medicare open enrollment period set to begin

Health Care - General Medicare - General Part D/Prescription Drugs

Arlene Sharp September 12, 2022September 12, 2022 Inflation

While Inflation Takes a Toll on Seniors, Billions of Dollars in Benefits Go Unused

By Judith Graham for Kaiser Health News Millions of older adults are having trouble making ends meet, especially during these

FDA Pandemic Part D/Prescription Drugs

Arlene Sharp September 6, 2022September 6, 2022

Omicron boosters: Do I need one, and if so, when?

By Allison Aubrey for NPR /Heard on Morning Edition September 5, 2022 The Centers for Disease Control and Prevention is

FDA Pandemic Part D/Prescription Drugs

Eileen Cook September 2, 2022September 1, 2022 COVID-19 Boosters, FDA

FDA authorizes Pfizer and Moderna Covid boosters targeted against Omicron strains

(By Matthew Herper for ST A T) The Food and Drug Administration on Wednesday authorized new Covid booster shots from

Legal Actions/Court Decisions Part D/Prescription Drugs

Eileen Cook September 1, 2022September 1, 2022 Drug copay assistance, Patient Advocacy Groups

3 patient groups sue US over drug copay assistance rule

(By Mackenzie Bean for Becker’s Hospital Review ) Three patient advocacy groups are suing the U.S. government to challenge the

FDA Pandemic Part D/Prescription Drugs

Eileen Cook August 31, 2022August 31, 2022 COVID-19 Boosters, FDA

FDA expected to authorize new omicron-specific COVID boosters this week

(By Rob Stein for NPR) The U.S. Food and Drug Administration this week is expected to authorize the first updated

Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook August 29, 2022August 29, 2022 medicare, Medicare Advantage, Medicare Part D

Keep an eye out for your Annual Notice of Change

Medicare recipients should receive their Annual Notice of Change (ANOC) by the end of September. This notice is generated by